Steven Cohen’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMLX
SVCM
Steven Cohen's AMLX Position: Q3 2026 in Review
Steven Cohen opened a new position in Amylyx Pharmaceuticals (AMLX) in Q3 2026: 388,699 shares worth $11.3M. The stake represents 0.01% of the portfolio and ranks #1278 among its holdings. This is a return to the name: Steven Cohen previously reported a position in AMLX as recently as Q1 2026.
Steven Cohen first reported a position in AMLX in Q2 2022 and has held it in 15 quarters since. The position peaked at $78.6M in Q4 2022. 228 funds tracked by Wall St. Rank hold AMLX as of Q3 2026.
- Steven Cohen held 388,699 shares of Amylyx Pharmaceuticals worth $11.3M as of Q3 2026.
- Amylyx Pharmaceuticals was a new Steven Cohen position in Q3 2026.
- Amylyx Pharmaceuticals made up 0.01% of Steven Cohen's portfolio in Q3 2026, its #1278 holding.
- Steven Cohen first reported a position in Amylyx Pharmaceuticals in Q2 2022 and has held it in 15 quarters since.
- Steven Cohen's Amylyx Pharmaceuticals position peaked at $78.6M in Q4 2022.
- 228 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.